PTGDR and neoplasm: As a result, we validated that overexpression of ZFPM2‐AS1 promoted tumor growth in vivo, and forced expression of ZFPM2 could abrogate the facilitative effect of ZFPM2‐AS1 overexpression (Fig. 7E–G).